Skip to content

Kluwer Patent Blog

Kluwer Patent Blog
  • Facebook
  • X
  • LinkedIn
  • YouTube

Account of profits

Account of profits is one of the remedies for patent infringement. Once a claimant has successfully proved liability, they can opt to prevent the unjustified enrichment of the defendant. This limits the award for the claimant to the sum of the profits made by the defendant.

The difficulty is determining which profits are part of the patentable invention. The account for profits cannot be unfair to the defendant so the profits might be split. As a result a forensic account with knowledge of the industry will usually make the assessments.

Other remedies for patent infringement are injunctions or damages.

(Indirect) infringement, Account of profits, Damages, Germany, Injunction

You Shall Not Lie! – Cost Risk in Patent Proceedings

Eike Schaper/August 17, 2010

The Duesseldorf Court of Appeal referred in a recent decision to the commandment “You shall not lie!” – with severe consequences as to the cost risk of patent proceedings (court order of 15 April 2010 – ref. I-2 W 10/10; InstGE 12, 107 – Du sollst nicht lügen!). Under German law, the losing party has…

Continue reading
(Indirect) infringement, Account of profits, Case Law, Damages, France

Waters v. Agilent et al., Court of First Instance Paris (Tribunal de Grande Instance Paris), 14 Januari 2009

Bruno Weil/January 14, 2009

This case provides a rather complete example of how to calculate damages in a patent infringement action in France. When the patent owner directly works out his patent in France, damages are based on lost profits and completed by additional royalties if the lost profits are below the amount of total infringing sales. When the…

Continue reading

Posts navigation

12
Wolters Kluwer

Go to posts on

(Compulsory) license (Cross-border) jurisdiction (Indirect) infringement Amendments Biologics Brexit Case Law Chemical Engineering Damages Denmark Enforcement EPC EPO EPO Decision Equivalents European Union Exceptions to patentability Extent of Protection France FRAND Germany Infringement Injunction Inventive step Italy Litigation Netherlands Novelty Opposition Patents Pharma Pharmaceutical patent Procedure Revocation Scope of protection SEP Spain SPC Sufficiency of disclosure Switzerland Unitary Patent United Kingdom United States of America UPC Validity
VAEPC-2024-edVissers Annotated European Patent Convention 2024 EditionKaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105
Annotated-PCTAnnotated PCTMalte Köllner€ 160
AI-GovernanceAI Governance and Liability in Europe: A Primer Ceyhun Necati Pehlivan, Nikolaus Forgó, Peggy Valcke€ 150

Number 3 in Top 10 Pharma Patent Blogs To Follow in 2022!

Pharma Patent Blogs

Blog Contributors

  • Brian Cordery
    Bristows
  • Rik Lambers
    Brinkhof
  • Rachel Mumby
    Bristows
  • Daniela Ampollini
    Trevisan & Cuonzo
  • Thorsten Bausch
    Hoffmann Eitle
  • Enrico Bonadio
    City, University of London
  • John Collins
    Clayton Utz
  • Matthieu Dhenne
    Dhenne Avocats
  • Simon Holzer
    MLL Legal Ltd.
  • Adam Lacy
    Hoffmann Eitle
  • Vaishali Mittal
    Anand and Anand
  • Miquel Montañá
    Clifford Chance
  • Roberto Rodrigues Pinho
    RNA Law
  • Alexa von Uexküll
    Vossius & Partner
  • Anders Valentin
    Bugge Valentin

Kluwer IP Law News Alert

Stay informed on Intellectual Property law & developments

Search Posts

RSS feeds

Summary Feed Article Feed

Related Sites

  • Kluwer IP Law
  • Kluwer Copyright Blog
  • Kluwer Trademark Blog
  • Regulating for Globalization Blog
  • Author Portal
Kluwer Logo

About us

  • About Kluwer Patent Blog
  • Kluwer IP Law
  • Kluwer Law International
  • E-store
  • Authors

Legal policy

  • User Agreement and Disclaimer
  • Editorial Policy & Guidelines
  • Privacy Policy and Use of Cookies

Contact

  • General Information
Back to top